March 7, 2023 — A virtual care team-guided strategy for guideline-directed medical therapy (GDMT) optimization was found ...
March 5, 2023 — Providing medications for chronic diseases—for example, cholesterol-lowering, blood pressure and ...
March 5, 2023 — Researchers demonstrated that a causal artificial intelligence (AI) system can accurately quantify how ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
March 5, 2023 — Patients with cardiovascular disease, such as heart disease, stroke or peripheral arterial disease, were ...
March 5, 2023 — Making a connection between the flu and the risk of subsequent heart problems significantly increased ...
March 5, 2023 — Doctors who received customized electronic health record (EHR) alerts for specific patients were 2.5 ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
March 5, 2023 — The number of deaths and disabling strokes among patients at low surgical risk who were treated with ...
March 5, 2023 — Patients with complex coronary artery disease who underwent a stenting procedure guided by intravascular ...
March 5, 2023 — In patients with multi-vessel heart disease who have had a heart attack, immediate treatment with stents ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 5, 2023 — In patients with heart failure and a poorly functioning heart valve, a minimally invasive procedure ...
March 5, 2023 — In the largest randomized trial conducted to compare minimally invasive and conventional cardiac ...
March 4, 2023 — Of the immense volume of valuable information offered and exchanged during the first day of the American ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 4, 2023 — The impact of statin use to prevent heart damage during a cancer patient’s chemotherapy was in focus ...
March 4, 2023 — Findings from the TRILUMINATE Pivotal Trial found no significant difference in survival or ...
March 4, 2023 - Lexicon Pharmaceuticals, Inc. announced new analyses of results from the SOLOIST-WHF Phase 3 outcomes ...
March 06, 2023
